Search results
Results from the WOW.Com Content Network
Lubiprostone, sold under the brand name Amitiza among others, is a medication used in the management of chronic idiopathic constipation, predominantly irritable bowel syndrome-associated constipation in women and opioid-induced constipation. The drug is owned by Mallinckrodt and is marketed by Takeda Pharmaceutical Company.
Plecanatide, sold under the brand name Trulance, is a medication for the treatment of chronic idiopathic constipation (CIC) [4] and irritable bowel syndrome with constipation. [5] It is available in India under the brand name Plectide (OQM Div, MSN Laboratories, India).
Linaclotide (Linzess) or Plecanatide (Trulance), which can help promote bowel regularity for people with chronic constipation or IBS. Lubiprostone (Amitiza), which can allow stool to pass more ...
Functional constipation, also known as chronic idiopathic constipation (CIC), is defined by less than three bowel movements per week, hard stools, severe straining, the sensation of anorectal blockage, the feeling of incomplete evacuation, and the need for manual maneuvers during feces, without organic abnormalities.
Constipation is more concerning when there is weight loss or anemia, blood is present in the stool, there is a history of inflammatory bowel disease or colon cancer in a person's family, or it is of new onset in someone who is older. [12] Treatment of constipation depends on the underlying cause and the duration that it has been present. [4]
U.S. Food and Drug Administration Grants Priority Review Status to AMITIZA ® (lubiprostone) Submission Seeking Approval for Treatment of Opioid-induced Constipation BETHESDA, Md. & DEERFIELD, Ill ...
They are used to treat and prevent constipation. Laxatives vary as to how they work and the side effects they may have. Certain stimulant, lubricant, and saline laxatives are used to evacuate the colon for rectal and bowel examinations, and may be supplemented by enemas under certain circumstances. Sufficiently high doses of laxatives may cause ...
Sucampo Pharmaceuticals recently heard back from the FDA regarding its supplemental new drug application for constipation drug Amitiza, which the company is looking to expand into an opioid ...